Pharma & Healthcare
Global Antivenom Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 11, 25
- ID: 301276
- Pages: 151
- Figures: 159
- Views: 1
In 2024, the global market size of Antivenom was estimated to be worth US$ 1041 million and is forecast to reach approximately US$ 1383 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.
Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
CSL is the world leading manufacturer in global Anti-Venom market with the market share of 27%, in terms of revenue, followed by Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech and MicroPharm. These 11 companies accounted for 68% of the revenue market share in 2019. Asia-Pacific, Middle East and Africa are the largest consumption regions, occupied about 77% of market share, in terms of volume. The application of Anti-Venom in hospital and clinics take the main global shares. The polyvalent Anti-Venom takes more global revenue shares compared to the Monovalent Anti-Venom, which accounts for 67% in 2019.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antivenom, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antivenom.
The Antivenom market size, estimations, and forecasts are provided in terms of sales volume (K Vials) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antivenom market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antivenom manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm
Segment by Type
Polyvalent antivenom
Monovalent antivenom
Segment by Application
Non-profit Institutions
Hospitals and Clinic
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Antivenom in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Antivenom manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antivenom sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
CSL is the world leading manufacturer in global Anti-Venom market with the market share of 27%, in terms of revenue, followed by Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech and MicroPharm. These 11 companies accounted for 68% of the revenue market share in 2019. Asia-Pacific, Middle East and Africa are the largest consumption regions, occupied about 77% of market share, in terms of volume. The application of Anti-Venom in hospital and clinics take the main global shares. The polyvalent Anti-Venom takes more global revenue shares compared to the Monovalent Anti-Venom, which accounts for 67% in 2019.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antivenom, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antivenom.
The Antivenom market size, estimations, and forecasts are provided in terms of sales volume (K Vials) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antivenom market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antivenom manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm
Segment by Type
Polyvalent antivenom
Monovalent antivenom
Segment by Application
Non-profit Institutions
Hospitals and Clinic
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Antivenom in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Antivenom manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antivenom sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Antivenom Product Introduction
1.2 Market by Type
1.2.1 Global Antivenom Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Polyvalent antivenom
1.2.3 Monovalent antivenom
1.3 Market by Application
1.3.1 Global Antivenom Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Non-profit Institutions
1.3.3 Hospitals and Clinic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antivenom Market Size Estimates and Forecasts
2.1.1 Global Antivenom Revenue 2020-2031
2.1.2 Global Antivenom Sales 2020-2031
2.2 Antivenom Market Size by Region: 2024 Versus 2031
2.3 Antivenom Sales by Region (2020-2031)
2.3.1 Global Antivenom Sales by Region: 2020-2025
2.3.2 Global Antivenom Sales Forecast by Region (2026-2031)
2.3.3 Global Antivenom Sales Market Share by Region (2020-2031)
2.4 Antivenom Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Antivenom Revenue by Region: 2020-2025
2.4.2 Global Antivenom Revenue Forecast by Region (2026-2031)
2.4.3 Global Antivenom Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Antivenom Sales by Type (2020-2031)
3.1.1.1 Global Antivenom Sales Volume by Type (2020-2031)
3.1.1.2 Global Antivenom Sales Market Share by Type (2020-2031)
3.1.2 Global Antivenom Revenue by Type (2020-2031)
3.1.2.1 Global Antivenom Revenue by Type (2020-2031)
3.1.2.2 Global Antivenom Revenue Market Share by Type (2020-2031)
3.1.3 Antivenom Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Antivenom Sales by Application (2020-2031)
3.2.1.1 Global Antivenom Sales Volume by Application (2020-2031)
3.2.1.2 Global Antivenom Sales Market Share by Application (2020-2031)
3.2.2 Global Antivenom Revenue by Application (2020-2031)
3.2.2.1 Global Antivenom Revenue by Application (2020-2031)
3.2.2.2 Global Antivenom Revenue Market Share by Application (2020-2031)
3.2.3 Antivenom Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Polyvalent antivenom of Antivenom Revenue Market Share by Application
3.3.2 Monovalent antivenom of Antivenom Revenue Market Share by Application
4 Global Antivenom by Manufacturers
4.1 Global Top Antivenom Manufacturers by Sales (2020-2025)
4.1.1 Global Antivenom Sales by Manufacturer (2020-2025)
4.1.2 Global Antivenom Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Antivenom Manufacturers by Revenue (2020-2025)
4.2.1 Global Antivenom Revenue by Manufacturer (2020-2025)
4.2.2 Global Antivenom Revenue Share by Manufacturer (2020-2025)
4.3 Global Antivenom Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Antivenom Manufacturers Covered: Ranking by Revenue
4.4.2 Global Antivenom Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Antivenom Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Antivenom Manufacturing Base Distribution, Product Type
4.5.1 Antivenom Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Antivenom Market
4.5.3 Manufacturers Antivenom Product Type and Application
4.5.4 Polyvalent antivenom Market Sales of Antivenom by Manufacturer
4.5.5 Monovalent antivenom Market Sales of Antivenom by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 CSL
5.1.1 CSL Company Information
5.1.2 CSL Description, Business Overview
5.1.3 CSL Antivenom Products Offered
5.1.4 CSL Antivenom Sales, Revenue and Gross Margin (2020-2025)
5.1.5 CSL Antivenom Sales by Product in 2024
5.1.6 CSL Antivenom Sales by Application in 2024
5.1.7 CSL Antivenom Sales by Geographic Area in 2024
5.1.8 CSL Recent Developments
5.2 Merck
5.2.1 Merck Company Information
5.2.2 Merck Description, Business Overview
5.2.3 Merck Antivenom Products Offered
5.2.4 Merck Antivenom Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Merck Antivenom Sales by Product in 2024
5.2.6 Merck Antivenom Sales by Application in 2024
5.2.7 Merck Antivenom Sales by Geographic Area in 2024
5.2.8 Merck Recent Developments
5.3 BTG
5.3.1 BTG Company Information
5.3.2 BTG Description, Business Overview
5.3.3 BTG Antivenom Products Offered
5.3.4 BTG Antivenom Sales, Revenue and Gross Margin (2020-2025)
5.3.5 BTG Antivenom Sales by Product in 2024
5.3.6 BTG Antivenom Sales by Application in 2024
5.3.7 BTG Antivenom Sales by Geographic Area in 2024
5.3.8 BTG Recent Developments
5.4 Pfizer
5.4.1 Pfizer Company Information
5.4.2 Pfizer Description, Business Overview
5.4.3 Pfizer Antivenom Products Offered
5.4.4 Pfizer Antivenom Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Pfizer Antivenom Sales by Product in 2024
5.4.6 Pfizer Antivenom Sales by Application in 2024
5.4.7 Pfizer Antivenom Sales by Geographic Area in 2024
5.4.8 Pfizer Recent Developments
5.5 Haffkine Bio-Pharmaceutical
5.5.1 Haffkine Bio-Pharmaceutical Company Information
5.5.2 Haffkine Bio-Pharmaceutical Description, Business Overview
5.5.3 Haffkine Bio-Pharmaceutical Antivenom Products Offered
5.5.4 Haffkine Bio-Pharmaceutical Antivenom Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Haffkine Bio-Pharmaceutical Antivenom Sales by Product in 2024
5.5.6 Haffkine Bio-Pharmaceutical Antivenom Sales by Application in 2024
5.5.7 Haffkine Bio-Pharmaceutical Antivenom Sales by Geographic Area in 2024
5.5.8 Haffkine Bio-Pharmaceutical Recent Developments
5.6 Rare Disease Therapeutics
5.6.1 Rare Disease Therapeutics Company Information
5.6.2 Rare Disease Therapeutics Description, Business Overview
5.6.3 Rare Disease Therapeutics Antivenom Products Offered
5.6.4 Rare Disease Therapeutics Antivenom Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Rare Disease Therapeutics Antivenom Sales by Product in 2024
5.6.6 Rare Disease Therapeutics Antivenom Sales by Application in 2024
5.6.7 Rare Disease Therapeutics Antivenom Sales by Geographic Area in 2024
5.6.8 Rare Disease Therapeutics Recent Developments
5.7 Flynn Pharma
5.7.1 Flynn Pharma Company Information
5.7.2 Flynn Pharma Description, Business Overview
5.7.3 Flynn Pharma Antivenom Products Offered
5.7.4 Flynn Pharma Antivenom Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Flynn Pharma Antivenom Sales by Product in 2024
5.7.6 Flynn Pharma Antivenom Sales by Application in 2024
5.7.7 Flynn Pharma Antivenom Sales by Geographic Area in 2024
5.7.8 Flynn Pharma Recent Developments
5.8 Vins Bioproducts
5.8.1 Vins Bioproducts Company Information
5.8.2 Vins Bioproducts Description, Business Overview
5.8.3 Vins Bioproducts Antivenom Products Offered
5.8.4 Vins Bioproducts Antivenom Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Vins Bioproducts Antivenom Sales by Product in 2024
5.8.6 Vins Bioproducts Antivenom Sales by Application in 2024
5.8.7 Vins Bioproducts Antivenom Sales by Geographic Area in 2024
5.8.8 Vins Bioproducts Recent Developments
5.9 Bharat Serums and Vaccines
5.9.1 Bharat Serums and Vaccines Company Information
5.9.2 Bharat Serums and Vaccines Description, Business Overview
5.9.3 Bharat Serums and Vaccines Antivenom Products Offered
5.9.4 Bharat Serums and Vaccines Antivenom Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Bharat Serums and Vaccines Antivenom Sales by Product in 2024
5.9.6 Bharat Serums and Vaccines Antivenom Sales by Application in 2024
5.9.7 Bharat Serums and Vaccines Antivenom Sales by Geographic Area in 2024
5.9.8 Bharat Serums and Vaccines Recent Developments
5.10 Serum Biotech
5.10.1 Serum Biotech Company Information
5.10.2 Serum Biotech Description, Business Overview
5.10.3 Serum Biotech Antivenom Products Offered
5.10.4 Serum Biotech Antivenom Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Serum Biotech Antivenom Sales by Product in 2024
5.10.6 Serum Biotech Antivenom Sales by Application in 2024
5.10.7 Serum Biotech Antivenom Sales by Geographic Area in 2024
5.10.8 Serum Biotech Recent Developments
5.11 MicroPharm
5.11.1 MicroPharm Company Information
5.11.2 MicroPharm Description, Business Overview
5.11.3 MicroPharm Antivenom Products Offered
5.11.4 MicroPharm Antivenom Sales, Revenue and Gross Margin (2020-2025)
5.11.5 MicroPharm Antivenom Sales by Product in 2024
5.11.6 MicroPharm Antivenom Sales by Application in 2024
5.11.7 MicroPharm Antivenom Sales by Geographic Area in 2024
5.11.8 MicroPharm Recent Developments
6 North America
6.1 North America Antivenom Market Size YoY Growth 2020-2031
6.2 North America Antivenom Market Facts & Figures by Country
6.2.1 North America Antivenom Sales by Country (2020-2031)
6.2.2 North America Antivenom Revenue by Country (2020-2031)
6.3 North America Antivenom Sales by Type (2020-2025)
6.4 North America Antivenom Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Antivenom Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Antivenom Market Facts & Figures by Region
7.2.1 Asia-Pacific Antivenom Sales by Region (2020-2031)
7.2.2 Asia-Pacific Antivenom Revenue by Region (2020-2031)
7.3 Asia-Pacific Antivenom Sales by Type (2020-2025)
7.4 Asia-Pacific Antivenom Sales by Application (2020-2025)
8 Europe
8.1 Europe Antivenom Market Size YoY Growth 2020-2031
8.2 Europe Antivenom Market Facts & Figures by Country
8.2.1 Europe Antivenom Sales by Country (2020-2031)
8.2.2 Europe Antivenom Revenue by Country (2020-2031)
8.3 Europe Antivenom Sales by Type (2020-2025)
8.4 Europe Antivenom Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Antivenom Market Size YoY Growth 2020-2031
9.2 Latin America Antivenom Market Facts & Figures by Country
9.2.1 Latin America Antivenom Sales by Country (2020-2031)
9.2.2 Latin America Antivenom Revenue by Country (2020-2031)
9.3 Latin America Antivenom Sales by Type (2020-2025)
9.4 Latin America Antivenom Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Antivenom Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Antivenom Market Facts & Figures by Country
10.2.1 Middle East and Africa Antivenom Sales by Country (2020-2031)
10.2.2 Middle East and Africa Antivenom Revenue by Country (2020-2031)
10.3 Middle East and Africa Antivenom Sales by Type (2020-2025)
10.4 Middle East and Africa Antivenom Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Antivenom Supply Chain Analysis
11.2 Antivenom Key Raw Materials and Upstream Suppliers
11.3 Antivenom Clients Analysis
11.4 Antivenom Sales Channel and Sales Model Analysis
11.4.1 Antivenom Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Antivenom Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Antivenom Distributors
12 Antivenom Market Dynamics
12.1 Antivenom Industry Trends
12.2 Antivenom Market Drivers
12.3 Antivenom Market Challenges
12.4 Antivenom Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Antivenom Product Introduction
1.2 Market by Type
1.2.1 Global Antivenom Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Polyvalent antivenom
1.2.3 Monovalent antivenom
1.3 Market by Application
1.3.1 Global Antivenom Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Non-profit Institutions
1.3.3 Hospitals and Clinic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antivenom Market Size Estimates and Forecasts
2.1.1 Global Antivenom Revenue 2020-2031
2.1.2 Global Antivenom Sales 2020-2031
2.2 Antivenom Market Size by Region: 2024 Versus 2031
2.3 Antivenom Sales by Region (2020-2031)
2.3.1 Global Antivenom Sales by Region: 2020-2025
2.3.2 Global Antivenom Sales Forecast by Region (2026-2031)
2.3.3 Global Antivenom Sales Market Share by Region (2020-2031)
2.4 Antivenom Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Antivenom Revenue by Region: 2020-2025
2.4.2 Global Antivenom Revenue Forecast by Region (2026-2031)
2.4.3 Global Antivenom Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Antivenom Sales by Type (2020-2031)
3.1.1.1 Global Antivenom Sales Volume by Type (2020-2031)
3.1.1.2 Global Antivenom Sales Market Share by Type (2020-2031)
3.1.2 Global Antivenom Revenue by Type (2020-2031)
3.1.2.1 Global Antivenom Revenue by Type (2020-2031)
3.1.2.2 Global Antivenom Revenue Market Share by Type (2020-2031)
3.1.3 Antivenom Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Antivenom Sales by Application (2020-2031)
3.2.1.1 Global Antivenom Sales Volume by Application (2020-2031)
3.2.1.2 Global Antivenom Sales Market Share by Application (2020-2031)
3.2.2 Global Antivenom Revenue by Application (2020-2031)
3.2.2.1 Global Antivenom Revenue by Application (2020-2031)
3.2.2.2 Global Antivenom Revenue Market Share by Application (2020-2031)
3.2.3 Antivenom Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Polyvalent antivenom of Antivenom Revenue Market Share by Application
3.3.2 Monovalent antivenom of Antivenom Revenue Market Share by Application
4 Global Antivenom by Manufacturers
4.1 Global Top Antivenom Manufacturers by Sales (2020-2025)
4.1.1 Global Antivenom Sales by Manufacturer (2020-2025)
4.1.2 Global Antivenom Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Antivenom Manufacturers by Revenue (2020-2025)
4.2.1 Global Antivenom Revenue by Manufacturer (2020-2025)
4.2.2 Global Antivenom Revenue Share by Manufacturer (2020-2025)
4.3 Global Antivenom Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Antivenom Manufacturers Covered: Ranking by Revenue
4.4.2 Global Antivenom Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Antivenom Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Antivenom Manufacturing Base Distribution, Product Type
4.5.1 Antivenom Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Antivenom Market
4.5.3 Manufacturers Antivenom Product Type and Application
4.5.4 Polyvalent antivenom Market Sales of Antivenom by Manufacturer
4.5.5 Monovalent antivenom Market Sales of Antivenom by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 CSL
5.1.1 CSL Company Information
5.1.2 CSL Description, Business Overview
5.1.3 CSL Antivenom Products Offered
5.1.4 CSL Antivenom Sales, Revenue and Gross Margin (2020-2025)
5.1.5 CSL Antivenom Sales by Product in 2024
5.1.6 CSL Antivenom Sales by Application in 2024
5.1.7 CSL Antivenom Sales by Geographic Area in 2024
5.1.8 CSL Recent Developments
5.2 Merck
5.2.1 Merck Company Information
5.2.2 Merck Description, Business Overview
5.2.3 Merck Antivenom Products Offered
5.2.4 Merck Antivenom Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Merck Antivenom Sales by Product in 2024
5.2.6 Merck Antivenom Sales by Application in 2024
5.2.7 Merck Antivenom Sales by Geographic Area in 2024
5.2.8 Merck Recent Developments
5.3 BTG
5.3.1 BTG Company Information
5.3.2 BTG Description, Business Overview
5.3.3 BTG Antivenom Products Offered
5.3.4 BTG Antivenom Sales, Revenue and Gross Margin (2020-2025)
5.3.5 BTG Antivenom Sales by Product in 2024
5.3.6 BTG Antivenom Sales by Application in 2024
5.3.7 BTG Antivenom Sales by Geographic Area in 2024
5.3.8 BTG Recent Developments
5.4 Pfizer
5.4.1 Pfizer Company Information
5.4.2 Pfizer Description, Business Overview
5.4.3 Pfizer Antivenom Products Offered
5.4.4 Pfizer Antivenom Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Pfizer Antivenom Sales by Product in 2024
5.4.6 Pfizer Antivenom Sales by Application in 2024
5.4.7 Pfizer Antivenom Sales by Geographic Area in 2024
5.4.8 Pfizer Recent Developments
5.5 Haffkine Bio-Pharmaceutical
5.5.1 Haffkine Bio-Pharmaceutical Company Information
5.5.2 Haffkine Bio-Pharmaceutical Description, Business Overview
5.5.3 Haffkine Bio-Pharmaceutical Antivenom Products Offered
5.5.4 Haffkine Bio-Pharmaceutical Antivenom Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Haffkine Bio-Pharmaceutical Antivenom Sales by Product in 2024
5.5.6 Haffkine Bio-Pharmaceutical Antivenom Sales by Application in 2024
5.5.7 Haffkine Bio-Pharmaceutical Antivenom Sales by Geographic Area in 2024
5.5.8 Haffkine Bio-Pharmaceutical Recent Developments
5.6 Rare Disease Therapeutics
5.6.1 Rare Disease Therapeutics Company Information
5.6.2 Rare Disease Therapeutics Description, Business Overview
5.6.3 Rare Disease Therapeutics Antivenom Products Offered
5.6.4 Rare Disease Therapeutics Antivenom Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Rare Disease Therapeutics Antivenom Sales by Product in 2024
5.6.6 Rare Disease Therapeutics Antivenom Sales by Application in 2024
5.6.7 Rare Disease Therapeutics Antivenom Sales by Geographic Area in 2024
5.6.8 Rare Disease Therapeutics Recent Developments
5.7 Flynn Pharma
5.7.1 Flynn Pharma Company Information
5.7.2 Flynn Pharma Description, Business Overview
5.7.3 Flynn Pharma Antivenom Products Offered
5.7.4 Flynn Pharma Antivenom Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Flynn Pharma Antivenom Sales by Product in 2024
5.7.6 Flynn Pharma Antivenom Sales by Application in 2024
5.7.7 Flynn Pharma Antivenom Sales by Geographic Area in 2024
5.7.8 Flynn Pharma Recent Developments
5.8 Vins Bioproducts
5.8.1 Vins Bioproducts Company Information
5.8.2 Vins Bioproducts Description, Business Overview
5.8.3 Vins Bioproducts Antivenom Products Offered
5.8.4 Vins Bioproducts Antivenom Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Vins Bioproducts Antivenom Sales by Product in 2024
5.8.6 Vins Bioproducts Antivenom Sales by Application in 2024
5.8.7 Vins Bioproducts Antivenom Sales by Geographic Area in 2024
5.8.8 Vins Bioproducts Recent Developments
5.9 Bharat Serums and Vaccines
5.9.1 Bharat Serums and Vaccines Company Information
5.9.2 Bharat Serums and Vaccines Description, Business Overview
5.9.3 Bharat Serums and Vaccines Antivenom Products Offered
5.9.4 Bharat Serums and Vaccines Antivenom Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Bharat Serums and Vaccines Antivenom Sales by Product in 2024
5.9.6 Bharat Serums and Vaccines Antivenom Sales by Application in 2024
5.9.7 Bharat Serums and Vaccines Antivenom Sales by Geographic Area in 2024
5.9.8 Bharat Serums and Vaccines Recent Developments
5.10 Serum Biotech
5.10.1 Serum Biotech Company Information
5.10.2 Serum Biotech Description, Business Overview
5.10.3 Serum Biotech Antivenom Products Offered
5.10.4 Serum Biotech Antivenom Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Serum Biotech Antivenom Sales by Product in 2024
5.10.6 Serum Biotech Antivenom Sales by Application in 2024
5.10.7 Serum Biotech Antivenom Sales by Geographic Area in 2024
5.10.8 Serum Biotech Recent Developments
5.11 MicroPharm
5.11.1 MicroPharm Company Information
5.11.2 MicroPharm Description, Business Overview
5.11.3 MicroPharm Antivenom Products Offered
5.11.4 MicroPharm Antivenom Sales, Revenue and Gross Margin (2020-2025)
5.11.5 MicroPharm Antivenom Sales by Product in 2024
5.11.6 MicroPharm Antivenom Sales by Application in 2024
5.11.7 MicroPharm Antivenom Sales by Geographic Area in 2024
5.11.8 MicroPharm Recent Developments
6 North America
6.1 North America Antivenom Market Size YoY Growth 2020-2031
6.2 North America Antivenom Market Facts & Figures by Country
6.2.1 North America Antivenom Sales by Country (2020-2031)
6.2.2 North America Antivenom Revenue by Country (2020-2031)
6.3 North America Antivenom Sales by Type (2020-2025)
6.4 North America Antivenom Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Antivenom Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Antivenom Market Facts & Figures by Region
7.2.1 Asia-Pacific Antivenom Sales by Region (2020-2031)
7.2.2 Asia-Pacific Antivenom Revenue by Region (2020-2031)
7.3 Asia-Pacific Antivenom Sales by Type (2020-2025)
7.4 Asia-Pacific Antivenom Sales by Application (2020-2025)
8 Europe
8.1 Europe Antivenom Market Size YoY Growth 2020-2031
8.2 Europe Antivenom Market Facts & Figures by Country
8.2.1 Europe Antivenom Sales by Country (2020-2031)
8.2.2 Europe Antivenom Revenue by Country (2020-2031)
8.3 Europe Antivenom Sales by Type (2020-2025)
8.4 Europe Antivenom Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Antivenom Market Size YoY Growth 2020-2031
9.2 Latin America Antivenom Market Facts & Figures by Country
9.2.1 Latin America Antivenom Sales by Country (2020-2031)
9.2.2 Latin America Antivenom Revenue by Country (2020-2031)
9.3 Latin America Antivenom Sales by Type (2020-2025)
9.4 Latin America Antivenom Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Antivenom Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Antivenom Market Facts & Figures by Country
10.2.1 Middle East and Africa Antivenom Sales by Country (2020-2031)
10.2.2 Middle East and Africa Antivenom Revenue by Country (2020-2031)
10.3 Middle East and Africa Antivenom Sales by Type (2020-2025)
10.4 Middle East and Africa Antivenom Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Antivenom Supply Chain Analysis
11.2 Antivenom Key Raw Materials and Upstream Suppliers
11.3 Antivenom Clients Analysis
11.4 Antivenom Sales Channel and Sales Model Analysis
11.4.1 Antivenom Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Antivenom Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Antivenom Distributors
12 Antivenom Market Dynamics
12.1 Antivenom Industry Trends
12.2 Antivenom Market Drivers
12.3 Antivenom Market Challenges
12.4 Antivenom Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Antivenom Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Antivenom Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Antivenom Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Antivenom Sales by Region (2020-2025) & (K Vials)
Table 5. Global Antivenom Sales Forecast by Region (2026-2031) & (K Vials)
Table 6. Global Antivenom Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Antivenom Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Antivenom Sales Volume by Type (2020-2025) & (K Vials)
Table 9. Global Antivenom Sales Volume by Type (2026-2031) & (K Vials)
Table 10. Global Antivenom Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Antivenom Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Antivenom Sales Volume by Application (2020-2025) & (K Vials)
Table 13. Global Antivenom Sales Volume by Application (2026-2031) & (K Vials)
Table 14. Global Antivenom Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Antivenom Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Antivenom Sales by Manufacturer (2020-2025) & (K Vials)
Table 17. Global Antivenom Sales Share by Manufacturer (2020-2025)
Table 18. Antivenom Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Antivenom Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Antivenom Price (2020-2025) & (USD/Vial)
Table 21. Ranking of Global Top Antivenom Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Antivenom Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Antivenom by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antivenom as of 2024)
Table 24. Antivenom Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Antivenom Market
Table 26. Manufacturers Antivenom Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. CSL Company Information
Table 29. CSL Description and Business Overview
Table 30. CSL Antivenom Product
Table 31. CSL Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 32. CSL Sales Proportion of Antivenom by Product in 2024
Table 33. CSL Sales Proportion of Antivenom by Application in 2024
Table 34. CSL Sales Proportion of Antivenom by Geographic Area in 2024
Table 35. CSL Recent Developments
Table 36. Merck Company Information
Table 37. Merck Description and Business Overview
Table 38. Merck Antivenom Product
Table 39. Merck Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 40. Merck Sales Proportion of Antivenom by Product in 2024
Table 41. Merck Sales Proportion of Antivenom by Application in 2024
Table 42. Merck Sales Proportion of Antivenom by Geographic Area in 2024
Table 43. Merck Recent Developments
Table 44. BTG Company Information
Table 45. BTG Description and Business Overview
Table 46. BTG Antivenom Product
Table 47. BTG Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 48. BTG Sales Proportion of Antivenom by Product in 2024
Table 49. BTG Sales Proportion of Antivenom by Application in 2024
Table 50. BTG Sales Proportion of Antivenom by Geographic Area in 2024
Table 51. BTG Recent Developments
Table 52. Pfizer Company Information
Table 53. Pfizer Description and Business Overview
Table 54. Pfizer Antivenom Product
Table 55. Pfizer Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 56. Pfizer Sales Proportion of Antivenom by Product in 2024
Table 57. Pfizer Sales Proportion of Antivenom by Application in 2024
Table 58. Pfizer Sales Proportion of Antivenom by Geographic Area in 2024
Table 59. Pfizer Recent Developments
Table 60. Haffkine Bio-Pharmaceutical Company Information
Table 61. Haffkine Bio-Pharmaceutical Description and Business Overview
Table 62. Haffkine Bio-Pharmaceutical Antivenom Product
Table 63. Haffkine Bio-Pharmaceutical Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 64. Haffkine Bio-Pharmaceutical Sales Proportion of Antivenom by Product in 2024
Table 65. Haffkine Bio-Pharmaceutical Sales Proportion of Antivenom by Application in 2024
Table 66. Haffkine Bio-Pharmaceutical Sales Proportion of Antivenom by Geographic Area in 2024
Table 67. Haffkine Bio-Pharmaceutical Recent Developments
Table 68. Rare Disease Therapeutics Company Information
Table 69. Rare Disease Therapeutics Description and Business Overview
Table 70. Rare Disease Therapeutics Antivenom Product
Table 71. Rare Disease Therapeutics Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 72. Rare Disease Therapeutics Sales Proportion of Antivenom by Product in 2024
Table 73. Rare Disease Therapeutics Sales Proportion of Antivenom by Application in 2024
Table 74. Rare Disease Therapeutics Sales Proportion of Antivenom by Geographic Area in 2024
Table 75. Rare Disease Therapeutics Recent Developments
Table 76. Flynn Pharma Company Information
Table 77. Flynn Pharma Description and Business Overview
Table 78. Flynn Pharma Antivenom Product
Table 79. Flynn Pharma Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 80. Flynn Pharma Sales Proportion of Antivenom by Product in 2024
Table 81. Flynn Pharma Sales Proportion of Antivenom by Application in 2024
Table 82. Flynn Pharma Sales Proportion of Antivenom by Geographic Area in 2024
Table 83. Flynn Pharma Recent Developments
Table 84. Vins Bioproducts Company Information
Table 85. Vins Bioproducts Description and Business Overview
Table 86. Vins Bioproducts Antivenom Product
Table 87. Vins Bioproducts Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 88. Vins Bioproducts Sales Proportion of Antivenom by Product in 2024
Table 89. Vins Bioproducts Sales Proportion of Antivenom by Application in 2024
Table 90. Vins Bioproducts Sales Proportion of Antivenom by Geographic Area in 2024
Table 91. Vins Bioproducts Recent Developments
Table 92. Bharat Serums and Vaccines Company Information
Table 93. Bharat Serums and Vaccines Description and Business Overview
Table 94. Bharat Serums and Vaccines Antivenom Product
Table 95. Bharat Serums and Vaccines Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 96. Bharat Serums and Vaccines Sales Proportion of Antivenom by Product in 2024
Table 97. Bharat Serums and Vaccines Sales Proportion of Antivenom by Application in 2024
Table 98. Bharat Serums and Vaccines Sales Proportion of Antivenom by Geographic Area in 2024
Table 99. Bharat Serums and Vaccines Recent Developments
Table 100. Serum Biotech Company Information
Table 101. Serum Biotech Description and Business Overview
Table 102. Serum Biotech Antivenom Product
Table 103. Serum Biotech Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 104. Serum Biotech Sales Proportion of Antivenom by Product in 2024
Table 105. Serum Biotech Sales Proportion of Antivenom by Application in 2024
Table 106. Serum Biotech Sales Proportion of Antivenom by Geographic Area in 2024
Table 107. Serum Biotech Recent Developments
Table 108. MicroPharm Company Information
Table 109. MicroPharm Description and Business Overview
Table 110. MicroPharm Antivenom Product
Table 111. MicroPharm Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 112. MicroPharm Sales Proportion of Antivenom by Product in 2024
Table 113. MicroPharm Sales Proportion of Antivenom by Application in 2024
Table 114. MicroPharm Sales Proportion of Antivenom by Geographic Area in 2024
Table 115. MicroPharm Recent Developments
Table 116. North America Antivenom Sales by Country (2020-2025) & (K Vials)
Table 117. North America Antivenom Sales by Country (2026-2031) & (K Vials)
Table 118. North America Antivenom Revenue by Country (2020-2025) & (US$ Million)
Table 119. North America Antivenom Revenue by Country (2026-2031) & (US$ Million)
Table 120. North America Antivenom Sales by Type (2020-2025) & (K Vials)
Table 121. North America Antivenom Sales by Application (2020-2025) & (K Vials)
Table 122. Asia-Pacific Antivenom Sales by Region (2020-2025) & (K Vials)
Table 123. Asia-Pacific Antivenom Sales by Region (2026-2031) & (K Vials)
Table 124. Asia-Pacific Antivenom Revenue by Region (2020-2025) & (US$ Million)
Table 125. Asia-Pacific Antivenom Revenue by Region (2026-2031) & (US$ Million)
Table 126. Asia-Pacific Antivenom Sales by Type (2020-2025) & (K Vials)
Table 127. Asia-Pacific Antivenom Sales by Application (2020-2025) & (K Vials)
Table 128. Europe Antivenom Sales by Country (2020-2025) & (K Vials)
Table 129. Europe Antivenom Sales by Country (2026-2031) & (K Vials)
Table 130. Europe Antivenom Revenue by Country (2020-2025) & (US$ Million)
Table 131. Europe Antivenom Revenue by Country (2026-2031) & (US$ Million)
Table 132. Europe Antivenom Sales by Type (2020-2025) & (K Vials)
Table 133. Europe Antivenom Sales by Application (2020-2025) & (K Vials)
Table 134. Latin America Antivenom Sales by Country (2020-2025) & (K Vials)
Table 135. Latin America Antivenom Sales by Country (2026-2031) & (K Vials)
Table 136. Latin America Antivenom Revenue by Country (2020-2025) & (US$ Million)
Table 137. Latin America Antivenom Revenue by Country (2026-2031) & (US$ Million)
Table 138. Latin America Antivenom Sales by Type (2020-2025) & (K Vials)
Table 139. Latin America Antivenom Sales by Application (2020-2025) & (K Vials)
Table 140. Middle East and Africa Antivenom Sales by Country (2020-2025) & (K Vials)
Table 141. Middle East and Africa Antivenom Sales by Country (2026-2031) & (K Vials)
Table 142. Middle East and Africa Antivenom Revenue by Country (2020-2025) & (US$ Million)
Table 143. Middle East and Africa Antivenom Revenue by Country (2026-2031) & (US$ Million)
Table 144. Middle East and Africa Antivenom Sales by Type (2020-2025) & (K Vials)
Table 145. Middle East and Africa Antivenom Sales by Application (2020-2025) & (K Vials)
Table 146. Antivenom Key Raw Materials, Industry Status and Trend
Table 147. Antivenom Key Raw Materials and Upstream Suppliers
Table 148. Antivenom Clients Status and Trend
Table 149. Antivenom Typical Clients
Table 150. Antivenom Distributors
Table 151. Antivenom Market Trends
Table 152. Antivenom Market Drivers
Table 153. Antivenom Market Challenges
Table 154. Antivenom Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
Table 158. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Antivenom Product Picture
Figure 2. Global Antivenom Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Antivenom Sales Market Share by Type in 2024 & 2031
Figure 4. Polyvalent antivenom Product Picture
Figure 5. Monovalent antivenom Product Picture
Figure 6. Global Antivenom Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Antivenom Sales Market Share by Application in 2024 & 2031
Figure 8. Non-profit Institutions
Figure 9. Hospitals and Clinic
Figure 10. Antivenom Report Years Considered
Figure 11. Global Antivenom Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Antivenom Market Size 2020-2031 (US$ Million)
Figure 13. Global Antivenom Sales 2020-2031 (K Vials)
Figure 14. Global Antivenom Sales Market Share Forecast by Region (2020-2031)
Figure 15. Global Antivenom Revenue Market Share by Region (2020-2031)
Figure 16. Global Antivenom Sales Market Share Forecast by Type (2020-2031)
Figure 17. Global Antivenom Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Antivenom Average Selling Price (ASP) by Type (2020-2025) & (USD/Vial)
Figure 19. Global Antivenom Sales Market Share Forecast by Application (2020-2031)
Figure 20. Global Antivenom Revenue Market Share Forecast by Application (2020-2031)
Figure 21. Antivenom Average Selling Price (ASP) by Application (2020-2025) & (USD/Vial)
Figure 22. Polyvalent antivenom of Antivenom Revenue Market Share by Application, 2024 VS 2031
Figure 23. Monovalent antivenom of Antivenom Revenue Market Share by Application, 2024 VS 2031
Figure 24. Global Antivenom Sales Share by Manufacturer in 2024
Figure 25. Antivenom Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Polyvalent antivenom Market Sales Proportion by Manufacturer in 2024
Figure 27. Monovalent antivenom Market Sales Proportion by Manufacturer in 2024
Figure 28. North America Antivenom Revenue 2020-2031 (US$ Million)
Figure 29. North America Antivenom Sales Market Share by Type (2020-2025)
Figure 30. North America Antivenom Sales Market Share by Application (2020-2025)
Figure 31. Asia-Pacific Antivenom Revenue 2020-2031 (US$ Million)
Figure 32. Asia-Pacific Antivenom Sales Market Share by Region (2020-2031)
Figure 33. Asia-Pacific Antivenom Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Antivenom Sales Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Antivenom Sales Market Share by Application (2020-2025)
Figure 36. Europe Antivenom Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Antivenom Sales Market Share by Country (2020-2031)
Figure 38. Europe Antivenom Revenue Market Share by Country (2020-2031)
Figure 39. Europe Antivenom Sales Market Share by Type (2020-2025)
Figure 40. Europe Antivenom Sales Market Share by Application (2020-2025)
Figure 41. Latin America Antivenom Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Antivenom Sales Market Share by Country (2020-2031)
Figure 43. Latin America Antivenom Revenue Market Share by Country (2020-2025)
Figure 44. Latin America Antivenom Sales Market Share by Type (2020-2025)
Figure 45. Latin America Antivenom Sales Market Share by Application (2020-2025)
Figure 46. Middle East and Africa Antivenom Revenue Growth Rate 2020-2031 (US$ Million)
Figure 47. Middle East and Africa Antivenom Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Antivenom Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Antivenom Sales Market Share by Type (2020-2025)
Figure 50. Middle East and Africa Antivenom Sales Market Share by Application (2020-2025)
Figure 51. Antivenom Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of Antivenom Raw Materials by Region in 2024
Figure 53. Antivenom Distribution Channels
Figure 54. Global Antivenom Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global Antivenom Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Table 1. Global Antivenom Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Antivenom Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Antivenom Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Antivenom Sales by Region (2020-2025) & (K Vials)
Table 5. Global Antivenom Sales Forecast by Region (2026-2031) & (K Vials)
Table 6. Global Antivenom Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Antivenom Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Antivenom Sales Volume by Type (2020-2025) & (K Vials)
Table 9. Global Antivenom Sales Volume by Type (2026-2031) & (K Vials)
Table 10. Global Antivenom Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Antivenom Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Antivenom Sales Volume by Application (2020-2025) & (K Vials)
Table 13. Global Antivenom Sales Volume by Application (2026-2031) & (K Vials)
Table 14. Global Antivenom Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Antivenom Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Antivenom Sales by Manufacturer (2020-2025) & (K Vials)
Table 17. Global Antivenom Sales Share by Manufacturer (2020-2025)
Table 18. Antivenom Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Antivenom Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Antivenom Price (2020-2025) & (USD/Vial)
Table 21. Ranking of Global Top Antivenom Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Antivenom Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Antivenom by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antivenom as of 2024)
Table 24. Antivenom Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Antivenom Market
Table 26. Manufacturers Antivenom Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. CSL Company Information
Table 29. CSL Description and Business Overview
Table 30. CSL Antivenom Product
Table 31. CSL Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 32. CSL Sales Proportion of Antivenom by Product in 2024
Table 33. CSL Sales Proportion of Antivenom by Application in 2024
Table 34. CSL Sales Proportion of Antivenom by Geographic Area in 2024
Table 35. CSL Recent Developments
Table 36. Merck Company Information
Table 37. Merck Description and Business Overview
Table 38. Merck Antivenom Product
Table 39. Merck Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 40. Merck Sales Proportion of Antivenom by Product in 2024
Table 41. Merck Sales Proportion of Antivenom by Application in 2024
Table 42. Merck Sales Proportion of Antivenom by Geographic Area in 2024
Table 43. Merck Recent Developments
Table 44. BTG Company Information
Table 45. BTG Description and Business Overview
Table 46. BTG Antivenom Product
Table 47. BTG Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 48. BTG Sales Proportion of Antivenom by Product in 2024
Table 49. BTG Sales Proportion of Antivenom by Application in 2024
Table 50. BTG Sales Proportion of Antivenom by Geographic Area in 2024
Table 51. BTG Recent Developments
Table 52. Pfizer Company Information
Table 53. Pfizer Description and Business Overview
Table 54. Pfizer Antivenom Product
Table 55. Pfizer Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 56. Pfizer Sales Proportion of Antivenom by Product in 2024
Table 57. Pfizer Sales Proportion of Antivenom by Application in 2024
Table 58. Pfizer Sales Proportion of Antivenom by Geographic Area in 2024
Table 59. Pfizer Recent Developments
Table 60. Haffkine Bio-Pharmaceutical Company Information
Table 61. Haffkine Bio-Pharmaceutical Description and Business Overview
Table 62. Haffkine Bio-Pharmaceutical Antivenom Product
Table 63. Haffkine Bio-Pharmaceutical Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 64. Haffkine Bio-Pharmaceutical Sales Proportion of Antivenom by Product in 2024
Table 65. Haffkine Bio-Pharmaceutical Sales Proportion of Antivenom by Application in 2024
Table 66. Haffkine Bio-Pharmaceutical Sales Proportion of Antivenom by Geographic Area in 2024
Table 67. Haffkine Bio-Pharmaceutical Recent Developments
Table 68. Rare Disease Therapeutics Company Information
Table 69. Rare Disease Therapeutics Description and Business Overview
Table 70. Rare Disease Therapeutics Antivenom Product
Table 71. Rare Disease Therapeutics Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 72. Rare Disease Therapeutics Sales Proportion of Antivenom by Product in 2024
Table 73. Rare Disease Therapeutics Sales Proportion of Antivenom by Application in 2024
Table 74. Rare Disease Therapeutics Sales Proportion of Antivenom by Geographic Area in 2024
Table 75. Rare Disease Therapeutics Recent Developments
Table 76. Flynn Pharma Company Information
Table 77. Flynn Pharma Description and Business Overview
Table 78. Flynn Pharma Antivenom Product
Table 79. Flynn Pharma Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 80. Flynn Pharma Sales Proportion of Antivenom by Product in 2024
Table 81. Flynn Pharma Sales Proportion of Antivenom by Application in 2024
Table 82. Flynn Pharma Sales Proportion of Antivenom by Geographic Area in 2024
Table 83. Flynn Pharma Recent Developments
Table 84. Vins Bioproducts Company Information
Table 85. Vins Bioproducts Description and Business Overview
Table 86. Vins Bioproducts Antivenom Product
Table 87. Vins Bioproducts Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 88. Vins Bioproducts Sales Proportion of Antivenom by Product in 2024
Table 89. Vins Bioproducts Sales Proportion of Antivenom by Application in 2024
Table 90. Vins Bioproducts Sales Proportion of Antivenom by Geographic Area in 2024
Table 91. Vins Bioproducts Recent Developments
Table 92. Bharat Serums and Vaccines Company Information
Table 93. Bharat Serums and Vaccines Description and Business Overview
Table 94. Bharat Serums and Vaccines Antivenom Product
Table 95. Bharat Serums and Vaccines Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 96. Bharat Serums and Vaccines Sales Proportion of Antivenom by Product in 2024
Table 97. Bharat Serums and Vaccines Sales Proportion of Antivenom by Application in 2024
Table 98. Bharat Serums and Vaccines Sales Proportion of Antivenom by Geographic Area in 2024
Table 99. Bharat Serums and Vaccines Recent Developments
Table 100. Serum Biotech Company Information
Table 101. Serum Biotech Description and Business Overview
Table 102. Serum Biotech Antivenom Product
Table 103. Serum Biotech Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 104. Serum Biotech Sales Proportion of Antivenom by Product in 2024
Table 105. Serum Biotech Sales Proportion of Antivenom by Application in 2024
Table 106. Serum Biotech Sales Proportion of Antivenom by Geographic Area in 2024
Table 107. Serum Biotech Recent Developments
Table 108. MicroPharm Company Information
Table 109. MicroPharm Description and Business Overview
Table 110. MicroPharm Antivenom Product
Table 111. MicroPharm Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 112. MicroPharm Sales Proportion of Antivenom by Product in 2024
Table 113. MicroPharm Sales Proportion of Antivenom by Application in 2024
Table 114. MicroPharm Sales Proportion of Antivenom by Geographic Area in 2024
Table 115. MicroPharm Recent Developments
Table 116. North America Antivenom Sales by Country (2020-2025) & (K Vials)
Table 117. North America Antivenom Sales by Country (2026-2031) & (K Vials)
Table 118. North America Antivenom Revenue by Country (2020-2025) & (US$ Million)
Table 119. North America Antivenom Revenue by Country (2026-2031) & (US$ Million)
Table 120. North America Antivenom Sales by Type (2020-2025) & (K Vials)
Table 121. North America Antivenom Sales by Application (2020-2025) & (K Vials)
Table 122. Asia-Pacific Antivenom Sales by Region (2020-2025) & (K Vials)
Table 123. Asia-Pacific Antivenom Sales by Region (2026-2031) & (K Vials)
Table 124. Asia-Pacific Antivenom Revenue by Region (2020-2025) & (US$ Million)
Table 125. Asia-Pacific Antivenom Revenue by Region (2026-2031) & (US$ Million)
Table 126. Asia-Pacific Antivenom Sales by Type (2020-2025) & (K Vials)
Table 127. Asia-Pacific Antivenom Sales by Application (2020-2025) & (K Vials)
Table 128. Europe Antivenom Sales by Country (2020-2025) & (K Vials)
Table 129. Europe Antivenom Sales by Country (2026-2031) & (K Vials)
Table 130. Europe Antivenom Revenue by Country (2020-2025) & (US$ Million)
Table 131. Europe Antivenom Revenue by Country (2026-2031) & (US$ Million)
Table 132. Europe Antivenom Sales by Type (2020-2025) & (K Vials)
Table 133. Europe Antivenom Sales by Application (2020-2025) & (K Vials)
Table 134. Latin America Antivenom Sales by Country (2020-2025) & (K Vials)
Table 135. Latin America Antivenom Sales by Country (2026-2031) & (K Vials)
Table 136. Latin America Antivenom Revenue by Country (2020-2025) & (US$ Million)
Table 137. Latin America Antivenom Revenue by Country (2026-2031) & (US$ Million)
Table 138. Latin America Antivenom Sales by Type (2020-2025) & (K Vials)
Table 139. Latin America Antivenom Sales by Application (2020-2025) & (K Vials)
Table 140. Middle East and Africa Antivenom Sales by Country (2020-2025) & (K Vials)
Table 141. Middle East and Africa Antivenom Sales by Country (2026-2031) & (K Vials)
Table 142. Middle East and Africa Antivenom Revenue by Country (2020-2025) & (US$ Million)
Table 143. Middle East and Africa Antivenom Revenue by Country (2026-2031) & (US$ Million)
Table 144. Middle East and Africa Antivenom Sales by Type (2020-2025) & (K Vials)
Table 145. Middle East and Africa Antivenom Sales by Application (2020-2025) & (K Vials)
Table 146. Antivenom Key Raw Materials, Industry Status and Trend
Table 147. Antivenom Key Raw Materials and Upstream Suppliers
Table 148. Antivenom Clients Status and Trend
Table 149. Antivenom Typical Clients
Table 150. Antivenom Distributors
Table 151. Antivenom Market Trends
Table 152. Antivenom Market Drivers
Table 153. Antivenom Market Challenges
Table 154. Antivenom Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
Table 158. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Antivenom Product Picture
Figure 2. Global Antivenom Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Antivenom Sales Market Share by Type in 2024 & 2031
Figure 4. Polyvalent antivenom Product Picture
Figure 5. Monovalent antivenom Product Picture
Figure 6. Global Antivenom Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Antivenom Sales Market Share by Application in 2024 & 2031
Figure 8. Non-profit Institutions
Figure 9. Hospitals and Clinic
Figure 10. Antivenom Report Years Considered
Figure 11. Global Antivenom Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Antivenom Market Size 2020-2031 (US$ Million)
Figure 13. Global Antivenom Sales 2020-2031 (K Vials)
Figure 14. Global Antivenom Sales Market Share Forecast by Region (2020-2031)
Figure 15. Global Antivenom Revenue Market Share by Region (2020-2031)
Figure 16. Global Antivenom Sales Market Share Forecast by Type (2020-2031)
Figure 17. Global Antivenom Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Antivenom Average Selling Price (ASP) by Type (2020-2025) & (USD/Vial)
Figure 19. Global Antivenom Sales Market Share Forecast by Application (2020-2031)
Figure 20. Global Antivenom Revenue Market Share Forecast by Application (2020-2031)
Figure 21. Antivenom Average Selling Price (ASP) by Application (2020-2025) & (USD/Vial)
Figure 22. Polyvalent antivenom of Antivenom Revenue Market Share by Application, 2024 VS 2031
Figure 23. Monovalent antivenom of Antivenom Revenue Market Share by Application, 2024 VS 2031
Figure 24. Global Antivenom Sales Share by Manufacturer in 2024
Figure 25. Antivenom Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Polyvalent antivenom Market Sales Proportion by Manufacturer in 2024
Figure 27. Monovalent antivenom Market Sales Proportion by Manufacturer in 2024
Figure 28. North America Antivenom Revenue 2020-2031 (US$ Million)
Figure 29. North America Antivenom Sales Market Share by Type (2020-2025)
Figure 30. North America Antivenom Sales Market Share by Application (2020-2025)
Figure 31. Asia-Pacific Antivenom Revenue 2020-2031 (US$ Million)
Figure 32. Asia-Pacific Antivenom Sales Market Share by Region (2020-2031)
Figure 33. Asia-Pacific Antivenom Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Antivenom Sales Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Antivenom Sales Market Share by Application (2020-2025)
Figure 36. Europe Antivenom Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Antivenom Sales Market Share by Country (2020-2031)
Figure 38. Europe Antivenom Revenue Market Share by Country (2020-2031)
Figure 39. Europe Antivenom Sales Market Share by Type (2020-2025)
Figure 40. Europe Antivenom Sales Market Share by Application (2020-2025)
Figure 41. Latin America Antivenom Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Antivenom Sales Market Share by Country (2020-2031)
Figure 43. Latin America Antivenom Revenue Market Share by Country (2020-2025)
Figure 44. Latin America Antivenom Sales Market Share by Type (2020-2025)
Figure 45. Latin America Antivenom Sales Market Share by Application (2020-2025)
Figure 46. Middle East and Africa Antivenom Revenue Growth Rate 2020-2031 (US$ Million)
Figure 47. Middle East and Africa Antivenom Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Antivenom Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Antivenom Sales Market Share by Type (2020-2025)
Figure 50. Middle East and Africa Antivenom Sales Market Share by Application (2020-2025)
Figure 51. Antivenom Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of Antivenom Raw Materials by Region in 2024
Figure 53. Antivenom Distribution Channels
Figure 54. Global Antivenom Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global Antivenom Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Medical Waste Fluid Solidifier Market Research Report 2025
Jun 12, 25
Global Metalized Bubble Material Market Research Report 2025
Jun 12, 25
Global 70% Isopropyl Rubbing Alcohol Market Research Report 2025
Jun 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232